Farshad Frozanpor

Farshad Frozanpor

Auto-generated profile, based on publicly available information

Farshad Frozanpor

Karolinska Institutet, Department of Surgery, Danderyd Hospital, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
EKEric Kullman
Eric Kullman
FFFarshad Frozanpor
Farshad Frozanpor
CSClaes Söderlund
Claes Söderlund
SLStefan Linder
Stefan Linder
PSPer Sandström
Per Sandström
OEOlle Eriksson
Olle Eriksson

1 June 2012 in Annals of Surgery
Verified
Journal Article
Closed access
FFFarshad Frozanpor
Farshad Frozanpor
LLLars Lundell
Lars Lundell
RSRalf Segersvärd
Ralf Segersvärd
UAUrban Arnelo
Urban Arnelo
To determine whether prophylactic pancreatic duct stenting reduces pancreatic fistula (PF) formation after distal pancreatectomy (DP). PF causes major morbidity after DP. Transpapillary pancreatic stenting has been proposed to be beneficial in treating established PF and also, prophylactically, to reduce the risk for PF after DP. Patients scheduled for DP during October 2006 to December 2010 were assessed and, if eligible, randomized to DP without (DP) or with stenting before transection of the neck of the gland (DP + stent). DP procedure was standardized and the follow-up period included the first 30 postoperative days. The outcomes were assessed according to the intention to treat analysis principle. : Sixty-four patients were assessed and 58 were randomized to either DP (n = 29) or DP + stent (n = 29). Mean ± SD operation time for DP was 218.8 ± 94.1 compared to 283.3 ± 131.9 for DP + stent (P = 0.052). Clinically significant PF (ISGPF [The International Study Group on Pancreatic Fistula] classification Grade B or C) occurred in 6 DP (22.2%) and 11 (42.3%) DP + stent patients (odds ratio: 2.57, 95% confidence interval 0.78-8.48; P = 0.122). The mean hospital stay for patients without stent was 13.4 ± 6.4 days compared to 19.4 ± 14.4 days for those provided with a pancreatic stent (P = 0.071). The results from this trial show that prophylactic pancreatic stenting does not reduce PF when performing a standardized resection of the body and tail of the pancreas. The trial was registered at clinicaltrials.gov NCT00500968.

30 June 2005 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
CSClaes Söderlund
Claes Söderlund
FFFarshad Frozanpor
Farshad Frozanpor
SLStefan Linder
Stefan Linder

27 March 2012 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
FFF. Frozanpor
F. Frozanpor
LLL. Loizou
L. Loizou
CAC. Ansorge
C. Ansorge
RSR. Segersvärd
R. Segersvärd
LLL. Lundell
L. Lundell
NAN. Albiin
N. Albiin

8 April 2014 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
FFFarshad Frozanpor
Farshad Frozanpor
LLLouiza Loizou
Louiza Loizou
CAChristoph Ansorge
Christoph Ansorge
LLLars Lundell
Lars Lundell
NANils Albiin
Nils Albiin
RSRalf Segersvärd
Ralf Segersvärd

6 September 2010
Verified
Journal Article
Closed access
FFFarshad Frozanpor
Farshad Frozanpor
NANils Albiin
Nils Albiin
SLStefan Linder
Stefan Linder
RSRalf Segersvärd
Ralf Segersvärd
LLLars Lundell
Lars Lundell
UAUrban Arnelo
Urban Arnelo